Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 161

Similar articles for PubMed (Select 14748274)

1.

Industry and the academy: conflicts of interest in contemporary health research.

Downie J, Baird P, Thompson J.

Health Law J. 2002;10:103-22. No abstract available.

PMID:
14748274
2.

Introduction to The Olivieri symposium.

Viens AM, Savulescu J.

J Med Ethics. 2004 Feb;30(1):1-7. No abstract available.

3.

Independent review adds to controversy at Sick Kids.

Shuchman M.

CMAJ. 1999 Feb 9;160(3):386-8. No abstract available.

4.
5.

Constraints of interest: lessons at the Hospital for Sick Children.

Phillips RA, Hoey J.

CMAJ. 1998 Oct 20;159(8):955-7. No abstract available. Erratum in: CMAJ 1998 Nov 17;159(10):1244.

6.

The Olivieri Report--a compelling study of the growing tensions in clinical research.

di Norcia V.

Sci Eng Ethics. 2003 Jan;9(1):125-32. No abstract available.

PMID:
12645235
7.

Controversial HSC clinical trials report made public. Hospital for Sick Children.

Birmingham K.

Nat Med. 1999 Jan;5(1):7. No abstract available.

PMID:
9883822
8.

Canadian whistleblower row prompts broader code of conduct.

Spurgeon D.

Nature. 1998 Dec 24-31;396(6713):715. No abstract available.

PMID:
9874365
9.
10.

The report of the committee of inquiry on the case involving Dr. Nancy Olivieri: a fiduciary law perspective.

Litman M, Sheremeta L.

Health Law Rev. 2002;10(2):3-13. No abstract available.

PMID:
15739307
11.

Academic freedom in clinical research.

Nathan DG, Weatherall DJ.

N Engl J Med. 2002 Oct 24;347(17):1368-71. No abstract available.

PMID:
12397199
12.

Dances with the pharmaceutical industry.

Gibson E, Baylis F, Lewis S.

CMAJ. 2002 Feb 19;166(4):448-50. No abstract available.

13.

The Olivieri case: lessons for Australasia.

Downie J, Thompson J, Baird P, Dodds S.

J Bioeth Inq. 2005;2(2):90-105.

PMID:
16317868
14.

HSC clinical trials controversy continues. Hospital for Sick Children.

Buchwald M, O'Brodovich H.

Nat Med. 1999 Jan;5(1):2-3. No abstract available.

PMID:
9883819
15.

Academia and industry: lessons from the unfortunate events in Toronto.

Nathan DG, Weatherall DJ.

Lancet. 1999 Mar 6;353(9155):771-2. No abstract available.

PMID:
10459956
16.

Olivieri to testify against Apotex in Europe.

Bonetta L.

Nat Med. 2001 Jun;7(6):644. No abstract available.

PMID:
11385480
17.

The deferiprone controversy: time to move on.

Naylor CD.

CMAJ. 2002 Feb 19;166(4):452-3. No abstract available.

18.

Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.

Tereskerz PM.

Account Res. 2003 Jul-Sep;10(3):137-58. No abstract available.

PMID:
14979317
19.

Report clears researcher who broke drug company agreement.

Spurgeon D.

BMJ. 2001 Nov 10;323(7321):1085. No abstract available.

20.

Conflicting interests: the evolution of an issue.

Healy D.

Monash Bioeth Rev. 2004 Oct;23(4):8-18.

PMID:
15688509
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk